Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wells Fargo Maintains Underweight on Mesa Laboratories, Lowers Price Target to $100

Author: Benzinga Newsdesk | May 30, 2025 08:33am
Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Underweight and lowers the price target from $120 to $100.

Posted In: MLAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist